ATE486964T1 - Molekulares verfahren zur diagnose von prostatakrebs - Google Patents

Molekulares verfahren zur diagnose von prostatakrebs

Info

Publication number
ATE486964T1
ATE486964T1 AT06790654T AT06790654T ATE486964T1 AT E486964 T1 ATE486964 T1 AT E486964T1 AT 06790654 T AT06790654 T AT 06790654T AT 06790654 T AT06790654 T AT 06790654T AT E486964 T1 ATE486964 T1 AT E486964T1
Authority
AT
Austria
Prior art keywords
marker genes
prostate cancer
prostate tissue
diagnosing prostate
molecular method
Prior art date
Application number
AT06790654T
Other languages
English (en)
Inventor
Nabil Belacel
Miroslava Cuperlovic-Culf
Rodney Ouellette
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Application granted granted Critical
Publication of ATE486964T1 publication Critical patent/ATE486964T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06790654T 2005-09-14 2006-09-08 Molekulares verfahren zur diagnose von prostatakrebs ATE486964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71650705P 2005-09-14 2005-09-14
PCT/CA2006/001477 WO2007030919A1 (en) 2005-09-14 2006-09-08 Molecular method for diagnosis of prostate cancer

Publications (1)

Publication Number Publication Date
ATE486964T1 true ATE486964T1 (de) 2010-11-15

Family

ID=37864588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06790654T ATE486964T1 (de) 2005-09-14 2006-09-08 Molekulares verfahren zur diagnose von prostatakrebs

Country Status (7)

Country Link
US (1) US7759060B2 (de)
EP (1) EP1934367B1 (de)
AT (1) ATE486964T1 (de)
CA (1) CA2622440A1 (de)
DE (1) DE602006018038D1 (de)
ES (1) ES2355430T3 (de)
WO (1) WO2007030919A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008012B2 (en) * 2002-01-24 2011-08-30 Health Discovery Corporation Biomarkers downregulated in prostate cancer
CA2829776A1 (en) 2011-03-14 2012-09-20 National Research Council Of Canada Prognostic marker sets for prostate cancer
GB201322034D0 (en) 2013-12-12 2014-01-29 Almac Diagnostics Ltd Prostate cancer classification
DE102014107380A1 (de) 2014-05-26 2015-11-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Verfahren zur Diagnose einer durch den alternativen Weg des Komplementsystems vermittelten Krankheit oder eines Risikos hierfür

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229774B2 (en) * 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
WO2003016484A2 (en) * 2001-08-17 2003-02-27 Affymetrix, Inc. Gleason grade 4/5 prostate cancer genes
US6949342B2 (en) * 2001-12-21 2005-09-27 Whitehead Institute For Biomedical Research Prostate cancer diagnosis and outcome prediction by expression analysis
US20040029151A1 (en) * 2002-04-09 2004-02-12 Affymetrix, Inc. Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
ITBZ20020040A1 (it) 2002-10-11 2004-04-12 Saverio Bettuzzi Metodo per la identificazione attraverso la progettazione e l'uso di appositi microchip -dna microarray della trasformazione tumorale del tessuto prostatico, valutazione della sua malignita' e prognosi del cancro prostatico umano mediante un nuovo me
WO2004091479A2 (en) * 2003-04-15 2004-10-28 Tularik Inc. Gene amplification and overexpression in cancer
ES2801379T3 (es) * 2003-12-01 2021-01-11 Epigenomics Ag Métodos y ácidos nucleicos para el análisis de la expresión génica asociada con el desarrollo de trastornos proliferativos de células de próstata

Also Published As

Publication number Publication date
WO2007030919A1 (en) 2007-03-22
CA2622440A1 (en) 2007-03-22
DE602006018038D1 (de) 2010-12-16
US20070065856A1 (en) 2007-03-22
US7759060B2 (en) 2010-07-20
ES2355430T3 (es) 2011-03-25
EP1934367A4 (de) 2008-10-15
EP1934367A1 (de) 2008-06-25
EP1934367B1 (de) 2010-11-03

Similar Documents

Publication Publication Date Title
WO2007093657A3 (es) Método para el diagnóstico molecular de cáncer de próstata y kit para implementar el método
WO2007072220A3 (en) Focused microarray and methods of diagnosing cancer
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
ATE333517T1 (de) Verfahren und sondenset zur erkennung von krebs
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
WO2006047483A3 (en) Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and pure fluid specimens
WO2015071876A3 (en) Use of microrna markers for diagnosis of thyroid tumors and a diagnostic panel containing such markers.
EP2527466A3 (de) Genetische Varianten auf CHR2 als Marker zur Verwendung bei der Beurteilung des Risikos, Diagnose, Prognose und Behandlung von Brustkrebs
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
ES2530843T3 (es) Métodos basados en microARN para el diagnóstico de cáncer de páncreas
MXPA03003281A (es) Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos.
WO2007123880A3 (en) Methods and kits for early stage caries detection
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
TW200626900A (en) Wnt proteins and detection and treatment of cancer
WO2005059160A3 (en) Identification and verification of methylation marker sequences
EP2021794B8 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
WO2011027310A8 (en) Novel tumor markers
WO2007033167A3 (en) Compositions and methods for detecting and treating cancer
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
ATE486964T1 (de) Molekulares verfahren zur diagnose von prostatakrebs
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
WO2002064015A3 (en) Pin1 as a marker for prostate cancer
WO2007141595A3 (en) Method of diagnosing breast cancer using protein markers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties